Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

Loss of living donor renal allograft survival advantage in children with focal segmental glomerulosclerosis

Go back to Resources

Loss of living donor renal allograft survival advantage in children with focal segmental glomerulosclerosis

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Effect of ablation optical zone diameter on spherical and cylindrical powers comparing PRK, PARK, LASIK, and A-LASIK

Go back to Resources

Effect of ablation optical zone diameter on spherical and cylindrical powers comparing PRK, PARK, LASIK, and A-LASIK

Authors:

Location:

Go back to Resources

Development of a Pediatric End-stage liver disease (PELD) score

Go back to Resources

Development of a Pediatric End-stage liver disease (PELD) score

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Current Cooperative Group phase III clinical trials in early stage breast cancer

Go back to Resources

Current Cooperative Group phase III clinical trials in early stage breast cancer

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children

Go back to Resources

Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Cord blood donor pre-screening: Impact of exclusion criteria on minority recruitment

Go back to Resources

Cord blood donor pre-screening: Impact of exclusion criteria on minority recruitment

Authors:

Location:

Go back to Resources

clinical trials STI571

Go back to Resources

clinical trials STI571

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Clinical trials referral resource. Health-related quality of life in cancer clinical trials (Part II)

Go back to Resources

Clinical trials referral resource. Health-related quality of life in cancer clinical trials (Part II)

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Clinical trials referral resource. Health-related quality of life in cancer clinical trials (Part I)

Go back to Resources

Clinical trials referral resource. Health-related quality of life in cancer clinical trials (Part I)

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Clinical trails referral resource. Current clinical trials of the anti-VEGF monoclonal antibody bevacizumab

Go back to Resources

Clinical trails referral resource. Current clinical trials of the anti-VEGF monoclonal antibody bevacizumab

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 129
  • Page 130
  • Page 131
  • Page 132
  • Current page 133
  • Page 134
  • Page 135
  • Page 136
  • Page 137
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • ISO Certification